共 50 条
- [1] IMPROVEMENTS IN EMOTIONAL LABILITY WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE TREATMENT IN CHILDREN WITH ADHD [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S257 - S257
- [2] CLINICAL RESPONSES AND SYMPTOMATIC REMISSIONS ACHIEVED WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE IN CHILDREN WITH ADHD [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S286 - S287
- [4] REAL-WORLD SAFETY PROFILE OF DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE FOR ADHD IN CHILDREN, ADOLESCENTS, AND ADULTS [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S213 - S213
- [5] POST HOC META-ANALYSIS OF MORNING AND EVENING BEHAVIORS IN CHILDREN WITH ADHD TREATED WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE FROM TWO PHASE 3 STUDIES [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S155 - S156
- [6] SAFETY OF EXTENDED-RELEASE METHYLPHENIDATE IN PRESCHOOL CHILDREN WITH ADHD [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S296 - S296
- [7] EFFICACY AND SAFETY OF DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE (DR/ER-MPH) IN CHILDREN WITH ADHD: RESULTS FROM A PIVOTAL PHASE 3 CLASSROOM TRIAL [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S166 - S166
- [8] DEVELOPMENT OF AN INTERACTIVE PHARMACOKINETIC DOSE-DEPENDENT DURATION MODEL FOR DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S191 - S191